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Diagnosis is not the end, but the beginning of practice. ~Martin H. Fischer 
1. Introduction 
Malaria is a protozoan infection (Najera &Hempel, 2006 as cited in Okwa & Ibidapo, 2010) 
with protean manifestations in the human species (Mohaptra, 2002; Murthy, 2000; Talib, 
1996) causing nearly one million deaths mainly in African children and decreasing gross 
domestic product by as much as 1.3% in countries with high disease rates (World Health 
Organization [WHO], 2010). Approximately half of the world’s population is at risk of 
malaria and in 2008; malaria was present in 108 countries and territories of the world 
(WHO, 2010). The most specific at risk population groups include young children in stable 
transmission areas, non immune pregnant women, semi immune pregnant women 
irrespective of HIV status, people with HIV/AIDS, international travelers to malaria 
endemic from non endemic areas as well as immigrants from endemic areas and their 
children living in non endemic areas returning to their home countries to visit friends and 
relatives (WHO, 2010). 
Making a diagnosis requires careful clinical examination and laboratory investigation. 
Whereas malaria could be over diagnosed in endemic areas, (Ammah et al, 1999; Gwer et al, 
2007; Hussain et al, 2009; Rehlis & Kurczewska, 2001; Rougemont et al, 2003; Smith et al, 
1994;) in the non endemic areas a high index of suspicion is usually required (Berrang –Ford 
et al, 2008). However, in the most vulnerable: neonates, under fives, (Dzeing-Ella et al 2005) 
pregnant women, the elderly and non immune( Sengoz inan et al,2010) who may develop 
potential life threatening complications of falciparum malaria, it is important in most cases to 
make a rapid, accurate diagnosis to ensure prompt treatment. WHO recommends that 
before giving treatment, clinical malaria should be confirmed by parasite –based diagnosis. 
Treatment given solely on the basis of symptoms (presumptive diagnosis and treatment) 
should only be considered when a parasitological diagnosis is not possible. In 2008, 33 of 43 
malaria endemic countries in the African region and 45 out of 63 countries in other regions 
were reported to have developed a policy of parasitological testing of suspected malaria 
cases in persons of all ages. However, policy development has not matched actual practice. 
Parasitological test for suspected malaria cases is carried out in less than 20% of individuals 






Moreover, the field of malaria diagnosis is rapidly expanding and bringing to fore hitherto 
unidentified issues both clinically and in the laboratory. Malaria, once thought to be rare in 
the newborn (Molyneux, 1989) has in recent times been increasingly reported (Falade et al, 
2007; Ibanesebor, 1995; Kamwendo et al, 2002; Lamikanra,1993; Lehner & Andrews, 1988; 
Muktar et al, 2006; Olowu et al, 2000; Opare,2010; Runsewe –Abiodun et al, 2006; Sowunmi 
et al, 1996) Incidences range from 0.3 to 33%in these areas ( Fisher, 2003) and has brought 
into question the extent of protection for the baby in the face of maternal placental infections 
such as HIV. Malaria infection is also described in the first 6 months of life which may be 
clinically indistinguishable from common bacterial and viral infections (Orogade, 2006).The 
use of clinical algorithms proposed for malaria diagnosis and their role as predictors for 
morbidity and mortality are being investigated (Tabitha et al, 2005). With the introduction of 
rapid diagnostic tests (RDTs) for diagnosis in malaria, there should be less need for 
presumptive diagnosis based solely on clinical features in high burden areas. However, 
there is a growing need to monitor and assess the performance of the RDTs in face of varied 
availability of RDTs and their low specificity and sensitivity in mixed malaria parasite 
infections. This chapter reviews these current issues in malaria diagnosis and discusses their 
implication for prompt malaria identification and treatment which are key aspects of the 
WHO policy and strategy for global malaria control. 
2. Clinical features in malaria 
2.1 Newborn 
2.1.1 Prevalence of congenital malaria 
Congenital malaria is defined as the presence of malaria parasites in the peripheral smear of 
the newborn within the first week of life (Mc Gregory, 1986). It had been thought to be rare 
due to the known effectiveness of placental barrier but recent reports from malaria endemic 
areas of incidence in small numbers were made. In a national multicenter study carried out 
to determine the epidemiology of congenital malaria in Nigeria (Falade et al, 2007), 1,875 
babies were assessed within the first 4 hours of life for parasitemia using freshly prepared 
Giemsa kept at pH 7.2 to stain conventional thick and methanol fixed thin blood smears. A 
prevalence of 5.1% of patent parasitemia was obtained. It was observed that the mean 
parasite density in these neonates was low (8-200/µl) as was also reported in an earlier 
study by Mc Guiness et al (1998). In about two thirds of these babies with parasitemia 
observed in the first 4 hours of life there was spontaneous parasite clearance by the second 
day of life, while 33.7% of them persisted and babies became symptomatic within the first 3 
days postpartum. 
2.1.2 Relationship between malaria in pregnancy and congenital malaria 
Antepartum maternal and placental parasitemia have been identified as consistent risk 
factors for congenital malaria (Orogade et al 2004,2008). Neonates in these studies who had 
peripartum malaria parasitemia had a 20 fold increased risk of infection. In Papua New 
Guinea, Lehner et al(1990) observed that where there was a maternal antepartum 
parasitaemia of 29.4%, there were corresponding cord and neonatal blood parasitemia of 
14.6% and 7.7%. They found a significant correlation between anti malarial IgG antibodies in 
paired maternal and cord blood which indicated transplacental transfer. Using the PCR 
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methods, Kamwenedo et al (2002) also working in Malawi had demonstrated that cord 
blood genotypes were a subset of the maternal and placental blood. An issue of current 
interest relating to the integrity of the placenta has been the role of HIV infection. In several 
recent studies (Steketee,2004; Ticconi et al, 2003; van Ejik et al, 2003; Verhoeff et al, 1999;), it 
has been found that HIV impaired the ability of pregnant women to control malaria 
parasitemia. Results from these studies showed that HIV-infected women experienced 
consistently higher prevalence of peripheral and placental malaria (summary relative risk = 
1.58 and 1.66, respectively), higher parasite densities, and more febrile illnesses, severe 
anemia, and adverse birth outcomes when compared with HIV-uninfected women, 
particularly in multigravidae. Thus, HIV alters the typical gravidity-specific pattern of 
malaria risk by shifting the burden from primarily primigravidae and secundigravidae to all 
pregnant women. 
2.1.3 Implication for malaria prophylaxis in pregnancy 
Maternal, especially perinatal malaria is a significant risk factor for congenital malaria. 
Intermittent preventive therapy (IpT) is recommended by WHO for pregnant women and 
infants in areas of high transmission in Sub Saharan Africa with stable malaria transmission 
who are particularly vulnerable to the consequences of malaria. This prophylaxis when 
adequately taken as two doses at least one month apart substantially reduces both maternal 
and neonatal morbidity and mortality related to malaria. However, the progress report on 
malaria prevention (WHO, 2010) indicates that coverage with Intermittent Preventive 
treatment for pregnant women ( IPTp) has remained far below the target levels. Thirty three 
out of 43 endemic countries in Africa had adopted the IPTp programme by 2009. Only 55% 
of all women attending antenatal clinics received the second dose of IPTp and since not all 
women attend antenatal clinic, household surveys in some countries report 2.4% to 62% 
with an overall weighted average of 12% received the second dose of therapy. This presents 
a picture that calls for urgent action to reduce maternal malaria and its consequences. 
2.1.4 Major clinical features in congenital malaraia 
The major clinical features in congenital are fever within the first 24 hours of life, refusal to 
suck and anaemia (Orogade et al, 2008). Fever is the most consistent feature while some 
other studies have described hepatosplenomegaly, jaundice, irritability. These are 
indistinguishable from features commonly seen in neonatal septicaemia. The implication of 
this is that every febrile neonate born to a mother who is epidemiologically vulnerable for 
malaria should be screened for malaria as well as other bacterial and viral infections. 
2.2 Zero – Five months 
2.2.1 Trend of malaria parasitaemia with age  
There have been variable findings in prevalence of malaria parasitemia in this age group, 
ranging from 0% in children less than 3 months (Okwa, 2000) to 17.2 % in the first six 
months of life (Orogade, 2006) and 27.1% in a similar series by Afolabi et al (2001). Age 
specific parasite rates showed a sharp drop in frequency of parasitemia from first to second 
week of life (Orogade, 2006), but this gradually increases with age till the sixth month of life. 






occurs in some babies at this time. It is noteworthy that about one fifth of all parasitemia 
occurs in the first month of life. The neonatal age group in this study formed a large burden 
of the disease prevalence. Mothers who were gravida 1-2, who did not utilize 
chemoprophylaxis in pregnancy and had education ranging from none to primary school 
level were important as risk factors for malaria parasitemia in this age group. These same 
risk factors have also been identified especially in malaria endemic regions where women in 
their first two pregnancies who develop maternal parasitemia have been identified as high 
risk for maternal anaemia and fetal complications such as fetal wastages, still births, 
premature deliveries and low birth weight in the newborn babies. In this study parasitemia 
documented in the first week of life would likely have resulted from congenital acquisition 
as prevalence of 9.31% obtained closely compares to the recent congenital malaria reports  
There is an average low mean parasite density rate of 64.82 ± 50.61/μL (Orogade, 2006)and 
this does not vary with age groups, χ2 ( Bartlett’s test) = 6.09, p=0.29. The mean Haematocrit 
is also significantly lower than controls low at 35.62 ± 7.09.%. Analysis of variants revealed a 
significant positive correlation between the mean haematocrit and malaria parasitemia. 
 Use of malaria prevention was 93.6% and this had a significant impact on reduction of 
parasitemia. Of the methods used for malaria prevention, window/door net screening 
and insecticides sprays were the most common. Less than half of mothers used bednets 
for their babies and only 7(2.8% )of these were insecticide treated bednets. Other non 
conventional methods used were local chemicals (ota pia-pia) sprayed on floors and walls 
in the rooms where the children slept. This apparently significantly reduced parasitemia 
where it was used one and half fold. Of all the babies seen only 47.4% were being 
exclusive breast fed. 
Beyond the neonatal period, the use of malaria prevention methods in particular ota pia-pia 
were significant for protection against malaria. Ota pia-pia which was used in 13.37% of 
cases seems to have been quite effective. This is a locally prepared chemical which when 
sprayed on floors and walls in the rooms are effective anti vector agents. However, the exact 
chemical compositions of these chemicals are yet to be fully analyzed and the safety of their 
use is not documented. Moreso, their potential harmful effects to the newborn and infant are 
unknown. Insecticide treated bednets have been introduced in Nigeria as an effective 
measure of malaria prophylaxis. However Orogade (2006) revealed a very poor utilization 
of this proven effective measure. Bednets, which has been a preventive measure of long 
standing use was utilized for less than half of the babies. There was rather more common 
use of window/door net screens as well as insecticide sprays which have also been known 
and in use for several years but which are not as effective.  
There was low educational status in more than a third of the mothers and this affects how 
well informed the mothers would be especially about health preventive matters. This less 
popular use of bednets as well as the level of health information the mothers may 
comprehend could explain the poor use of treated bednets. Socioeconomic status of families, 
though not investigated in this study has been found to be a reflection of the choice of 
malaria preventive measures, in this region. Socioeconomic status determines the economic 
power to sustain the preventive measure chosen, so cheaper, locally made and available 
means would be more acceptable.  
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2.2.2 Clinical effects of parasitemia 
The major clinical symptoms apart from fever were cough, diarrhea generalized rash, 
excessive crying and vomiting ( Afolabi, 2001; Orogade, 2006). All these symptoms are non 
specific but had about one half to two fold occurrence in children with malaria than in 
others without malaria parasitemia. Fever however seems to be the most constant factor 
even in the older infant and children. The babies had a low mean temperature of 37.7°C ± 
0.58 and respiratory distress with respiratory rate of 45.66 ± 21.6 cycles/minute. 
Dehydration, palmar pallor, jaundice and hepatomegaly were the commonest signs though 
not of significant relationship. Palmar pallor is not a good indicator of anaemia χ2 = 1.24, p= 
0.264. The children with parasitemia had relatively low grade fever with mean temperatures 
of 37.7 ± 0.58 and tachycardia, mean pulse rate of 137.67 ± 9.94..Overall most of the clinical 
features were non-specific and could not be attributable to only malaria. Malaria in the 
children aged 0-5 months though the prevalences and parasite densities are lower, yet it 
produces significant morbidity in the children. Prevention of malaria in the pregnant 
women by chemoprophylaxis is still an area that requires focus and advocacy and public 
enlightenment on the use of insecticide treated nets for more widespread use is needed.  
2.3 Six months – Five years 
2.3.1 Clinical features of complicated and uncomplicated malaria 
In the areas of stable malaria transmission, this group of children are the most affected in 
morbidity and mortality. Reporting the findings of severe malaria in Gabonese children, 
children Dzeing-Ella et al (2005) observed that most children with severe malaria are under 
5 years old. Commonest features were anaemia, respiratory distress, cerebral malaria 
hypoglycaemia. Anaemia was commoner in children under 18 months of age, while cerebral 
malaria was commoner above 18 months. Poor prognostic factors were coma, 
hyperlactaemia and hypoglycaemia. Another study reporting uncomplicated malaria in 
febrile under 5 years children ( Ikeh & Teclaire, 2008) showed prevalences of about 52.2% 
and the most common presentation was fever. Most of the children within this age group at 
are various levels of developing immunity and yet have parasite rates that could range from 
80-90%. This explains their potential to develop severe malaria. 
2.3.2 Use of clinical algorithms and predictors for malaria morbidity and mortality 
Development of clinical algorithms were initially done as guidelines to ensure that the 
young child at risk of potentially fatal diseases were identified and received prompt 
attention and commenced some management at the community level. In this guideline, the 
Integrated Management of Childhood Diseases [IMCI], children under 5 years of age, living 
in areas of high malaria endemicity were to be treated for malaria if they presented to a 
health facility with fever, temp >37. 5˚C. Studies by Tabitha et al (2005) found in a study that 
using a set of symptoms and signs with highest sensitivity and specificity and comparing 
these to parasitemia, a significant proportion of patients would have been sent home 
untreated. This tendency increased with increasing age. In situations as alluded to by the 
report of Khan et al (2005), the other issue was that often there were co-morbidities in febrile 
illness in some communities. Simply using algorithms for treatment of malaria might also 






was commonly observed in their study. Algorithms on the one hand may lead to 
wastefulness of treatment supplies and on the other hand endanger lives for other possibly 
life threatening conditions.  
2.4 School aged 5-12years  
2.4.1 Asymptomatic malaria parasitemia and its implication for malaria control 
The school aged child in an area of high endemicity typically has malaria parasite 
prevalence rates of up to 75%. Despite this high rates of parasitemia, theses children largely 
remain asymptomatic, having developed sufficient immunity which is both antiparastic and 
antitoxic to keep them from having clinical infection (Bruce Chwatt et al as cited by Orogade 
et al, 2002). In their study, Orogade et al (2002) also observed that these asymptomatic 
children had high levels of gametocytaemia (65%). Possible association between 
asymptomatic parasitemia and the utilization of vector control measures were analyzed. 
Vector control measure utilization was strongly related and inversely associated with the 
rates of ASMP. The estimation of ASMP is therefore recommended for use as an index for 
evaluation of malaria vector control programmes.  
3. Laboratory diagnosis in malaria 
3.1 Role of presumptive versus laboratory diagnosis for treatment 
The policy and strategies for Malaria control by the WHO hinges on Malaria prevention, 
diagnosis and treatment. Diagnosis of malaria has been a challenge in both endemic and non 
endemic countries alike: the former having overdiagnosis with consequences of wastage of 
resources for treatment, excessive drug pressure and antimalarial drug resistance and the 
latter under diagnosis or even missed diagnosis which in some cases lead to malaria 
mortality. Gwer et al (2007) in an over view of problems associated with overdiagnosis in 
severe malaria identified the unavailability and unreliable parasitological confirmation of 
parasitemia as the greatest challenge in endemic countries.  
The commonest symptom of malaria is fever and the subject of how many febrile episodes 
in susceptible populations in endemic areas even in the face of detectable parasitemia is 
attributable to malaria has been of immense research. Mc Guiness et al (1998) proposed 
some clinical case definitions for malaria in southern Ghana. Using logistic regression to 
model fever risk as continuous function of parasite density, fever attributable to malaria was 
defined by season and age groups. It was concluded that attributable fever was 51% and 
22% in wet and dry seasons respectively for infants while in the children older than one 
year, it was higher in both seasons: 89% and 36% respectively. They also observed a lower 
estimated parasite density threshold for initiation of a febrile episode in infants than the 
older child. In another study Rougement et al (1991) working in Niger, West Africa 
investigated parasitemia based on 3 criteria of febrile episodes: the duration, intensity and 
possibility of a non malarial cause. The proportion of febrile cases attributable to 
parasitemia ranged from 0 to 0.92 but there was no association between parasitemia and low 
intensity fevers, or fever of greater than 3 days duration in the presence of an obvious non 
malaria cause. They however also found highly significant relationship between parasitemia 
and fever in the high transmission season. It seems from these studies that making a 
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diagnosis by clinical case definitions based on epidemiological factors may be a useful tool 
in areas where laboratory facilities are not always available or reliable.  
However, Valerie et al (2010) again observed from studies done over 20years that there was 
a growing decline in malaria transmission in East Africa and a subsequent proportion of 
fever associated with Plasmodium falciparum. They concluded that the decline provides 
evidence for policy change from presumptive antimalarial therapy to laboratory diagnosis 
before treatment (Valerie et al 2009, 2010). Much has gone into training of personnel for 
laboratory diagnosis and as Ngasala et al (2008) reported on the impact of training in clinical 
and microscopy diagnosis of childhood malarial on prescription and health outcome: 
microscopy reduces prescription but there is great variation in accuracy of readings. With 
this observation, the caution by English et al (2009) might be only apt that rapid universal 
policy change that abandons presumptive antimalarial treatment for African children might 
be premature and in fact cause more harm than good. 
3.2 Comparisons between rapid diagnostic tests and microscopy in malaria  
The gold standard for malaria parasite identification and quantification has been the 
microscopic examination of thick and fixed thin blood smears using Giemsa stain. In cases 
of anticipated low malaria parasite densities, care should be taken to maintain the pH of the 
stain around 7 and a freshly prepared stain achieves better results (Orogade et al, 2008). 
Other techniques utilised to enhance microscopy include the acridine orange fluorescent 
technique ( Keiser el al, 2002; Lowe et al, 1996; Nicholas, 1997). This has proved to be quite 
useful but requires the additional requirements of fluorescent microscopy. Maintenance of a 
good quality, effective microscopy service involves the provision of high quality supplies, 
reagents, microscopes as well as technical competence and an adequate work environment 
to prepare usable blood films (Coleman et al, 2002; Durrheim et al, 1997, Kachur et al, 1998; 
Kain et al, 1998; Kilan et al, 2000; Omeara et al, 2005 as cited in Bell et al, 2006).  
Obstacles to lab diagnosis of malaria as have been reported in Mali (Dolo et al, 2010) are the 
same experience in most developing countries where malaria is endemic. These 
includeunderuse of laboratory diagnosis by clinicians, absence of qualified laboratory facilities 
in some locations, and poor continuous professional education of laboratory technicians. 
Introduction of Rapid Diagnostic tests was intended to fill the need for accuracy, speed and 
reliability which standard microscopy has fallen short of. These are antigen detecting rapid 
diagnostic tests which detect the histidine rich protein 2(HRP2) and Plasmodium lactate 
dehydrogenase(pLDH) which are usually produced during the erythrocytic cycle. Several 
studies have evaluated the effectiveness of these tests compared with microscopy and the 
results have consistently shown high sensitivity and specificity but inability to differentiate 
mixed infections (Chinkhumba, 2010; Gatti et al, 2007; Tomas et al, 2001). However the 
successful implementation of RDT has been bedevilled by poor product performance, 
inadequate methods to determine the quality of products and a lack of emphasis and 
capacity to deal with these.(Bell et al 2006) Another group (Christopher et al, 2008) described 
the limitations of RDTs as having: all or none test results, inability to diagnose non 
falciparum malaria, variable heat stability and safety risks related to blood sampling 
(especially HIV and hepatitis B). Also of equal concern is that negative RDT results are often 






3.3 Provision of centralised rapid diagnostic test centres for more efficient diagnosis 
To ascertain some degree of quality assurance and uniformity of results there is need to 
develop centralised RDT centres. These centres serve for purchase, transport, storage of 
RDTs kits as well as provide training for personnel that administer the tests at community 
level. It could serve as a reference laboratory since there are more highly skilled personnel 
and results of tests could be ascertained. Church et al (2003), describe such a centre which 
has supported and facilitated the RDT programme. Bastiaens et al (2011) have described 
results of researches carried on at such centres which showed improved diagnosis of 
malaria when government policy changed to implementation of testing before treatment in 
malaria. However, Derua et al (2011), describe in their study the perception of the users and 
health service providers which were dissimilar. Whereas the clinicians and patients were 
satisfied with the overall performance of the labs, the laboratory personnel expressed 
dissatisfaction over working conditions and some details of laboratory procedures. This 
signal is worth more investigation across regional centres so that the efforts gained would 
not be undermined. There is also noted that there is need to integrate these services into 
existing healthcare services to ensure sustainability in the long run. 
3.4 Newer microscopic techniques 
Due to the limitations of the rapid diagnostic tests already noted, the RDTs are not the end 
in malaria diagnosis. Using Polymerase chain reaction (PCR) techniques some of the 
limitations have been overcome. Myjak et al (2002), describe PCR techniques that have been 
utilised to enhance malaria diagnosis in mixed infections and especially in patients with low 
parasite densities, while Patsoula et al (2003) reported a single step PCR based method to 
differentiate mixed infections and Ahmet et al ( 2010) have used nested PCR and Real-Time 
PCR for detection of Plasmodium vivax.  
Reliable enumeration of malaria parasites in thick blood film using digital analysis is also 
described by Frean (2009). 
3.5 Other non specific laboratory tests in malaria diagnosis 
Some workers have identified some other non malaria haematological indicators of the 
diagnosis and course of malaria (Ida E et al, 2007). Such include low levels of thrombocyte, 
leucocytes and coagulation factors II- VII-X as well as raised levels of C-reactive protein, 
lactate dehydrogenase and bilirubin. It is suggested that these could serve as markers of 
active disease as well as for monitoring during treatment and especially so when malaria 
parasites are difficult to identify. 
4. Conclusion 
• There has been tremendous increase in research in malaria diagnosis in the last decade. 
• There should be an increased awareness and identification of congenital, neonatal and 
early infancy malaria especially in endemic areas. This also calls for closer monitoring 
and care of the pregnant woman at risk of malaria infection 
• Clinical algorithms for malaria diagnosis are not sensitive enough for predicting 
morbidity or mortality. 
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• Reliance on rapid diagnostic tests should be put into context. Areas with mixed malaria 
parasite infection would need some other confirmatory tests while in other areas, 
uncertain distribution of reagents and trained personnel could limit the effectiveness of 
RDTs in diagnosis. 
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